Ethanol extract from Portulaca oleracea L. attenuated acetaminophen-induced mice liver injury

American Journal of Translational Research

Volumn 7, Issue 2, 2015, Pages 309-318

  Liu, Xue Feng ^a   Zheng, Cheng Gang ^b   Shi, Hong Guang ^f   Tang, Gu Sheng ^c   Wang, Wan Yin ^b   Zhou, Juan ^d   Dong, Li Wei ^e  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

^c SECOND MILITARY MEDICAL UNIVERSITY   (China)

^d Center Lab of Shanghai Fifth Hospital   (China)

^e Eastern Institute of Hepatobiliary Surgery   (China)

^f 401 Hospital of PLA   (China)

Author keywords

Acetaminophen; Antioxidation; Inflammation; Liver injury; Portulaca oleracea L

Indexed keywords

ADENINE NUCLEOTIDE TRANSLOCASE; ALANINE AMINOTRANSFERASE; ALPHA INTERFERON; AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; COPPER ZINC SUPEROXIDE DISMUTASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; INTERLEUKIN 1ALPHA; INTERLEUKIN 6; MALONALDEHYDE; MANGANESE SUPEROXIDE DISMUTASE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 9; PARACETAMOL; PORTULACA OLERACEA EXTRACT; REACTIVE OXYGEN METABOLITE; STRESS ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE 1; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CELL DAMAGE; CONTROLLED STUDY; DNA FRAGMENTATION; DRUG DOSE COMPARISON; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PHOSPHORYLATION; HISTOLOGY; LIVER TOXICITY; MALE; MOUSE; NICK END LABELING; NONHUMAN; PORTULACA OLERACEA; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

MUS; PORTULACA OLERACEA;

EID: 84925452765     PISSN: None     EISSN: 19438141     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Jaeschke H and Bajt ML. Intracellular signaling mechanisms of acetaminophen-induced liver cell death. Toxicol Sci 2006; 89: 31-41.
2. Larrey D and Pageaux GP. Drug-induced acute liver failure. Eur J Gastroenterol Hepatol 2005; 17: 141-143.
3. Takemoto K, Hatano E, Iwaisako K, Takeiri M, Noma N, Ohmae S, Toriguchi K, Tanabe K, Tanaka H and Seo S. Necrostatin-1 protects against reactive oxygen species (ROS)-indu-ced hepatotoxicity in acetaminophen-induced acute liver failure. FEBS Open Bio 2014; 4: 777-787.
4. Kon K, Kim JS, Jaeschke H and Lemasters JJ. Mitochondrial permeability transition in acet-aminophen-induced necrosis and apoptosis of cultured mouse hepatocytes. Hepatology 2004; 40: 1170-1179.
5. Honmore V, Kandhare A, Zanwar AA, Rojatkar S, Bodhankar S and Natu A. Artemisia pallens alleviates acetaminophen induced toxicity via modulation of endogenous biomarkers. Pharm Biol 2015; 53: 571-81.
6. Prescott LF, Ballantyne A, Proudfoot AT, Park J and Adriaenssens P. Treatment of paracetamol (acetaminophen) poisoning with N-acetylcy-steine. Lancet 1977; 310: 432-434.
7. Polson J and Lee WM. AASLD position paper: the management of acute liver failure. Hepatology 2005; 41: 1179-1197.
8. Lauterburg BH, Corcoran GB and Mitchell JR. Mechanism of action of N-acetylcysteine in the protection against the hepatotoxicity of acet-aminophen in rats in vivo. J Clin Invest 1983; 71: 980.
9. Abdelmegeed MA, Jang S, Banerjee A, Har-dwick JP and Song BJ. Robust protein nitration contributes to acetaminophen-induced mitochondrial dysfunction and acute liver injury. Free Radic Biol Med 2013; 60: 211-222.
10. Yang R, Miki K, He X, Killeen ME and Fink MP. Prolonged treatment with N-acetylcystine de-lays liver recovery from acetaminophen hepatotoxicity. Crit Care 2009; 13: R55.
11. Jaeschke H. Role of inflammation in the mechanism of acetaminophen-induced hepatotoxicity. Expert Opin Drug Meta Toxicol 2005; 1: 389-397.
12. Blazka ME, Elwell MR, Holladay SD, Wilson RE and Luster MI. Histopathology of acetamino-phen-induced liver changes: role of interleukin 1α and tumor necrosis factor α. Toxicol Pathol 1996; 24: 181-189.
13. Ishida Y, Kondo T, Ohshima T, Fujiwara H, Iwa-kura Y and Mukaida N. A pivotal involvement of IFN-γ in the pathogenesis of acetaminophen-induced acute liver injury. FASEB J 2002; 16: 1227-1236.
14. Hu LF, Xu XY and Wang BQ. Research and utili-zation situation of Portulaca Oleracea L in China. Pract J Med Pharm 2003; 20: 315-316.
15. Xiang L, Xing D, Wang W, Wang R, Ding Y and Du L. Alkaloids from Portulaca oleracea L. Phytochemistry 2005; 66: 2595-2601.
16. Rashed AN, Afifi FU and Disi AM. Simple evalu-ation of the wound healing activity of a crude extract of Portulaca oleracea L. (growing in Jordan) in Mus musculus JVI-1. J Ethnopharmacol 2003; 88: 131-136.
17. Zhang XJ, Ji YB, Qu Z, Xia J and Wang L. Ex-perimental studies on antibiotic functions of Portulaca oleracea L. in vitro. Chin J Microecol 2002; 14: 277-280.
18. Liu LX, Howe P, Zhou YF, Xu ZQ, Hocart C and Zhang R. Fatty acids and b-carotene in Aus-tralian purslane (Portulaca oleracea) varieties. J Chromatogr 2000; 893: 207-213.
19. Awad NE. Lipid content and antimicrobial activity of phenolic constituents of cultivated Portulaca oleracea L. Bull Facul Pharm Cairo Uni 1994; 32: 137-142.
20. Sakai N, Inada K, Okamoto M, Shizuri Y and Fukuyama Y. Portuloside A, a monoterpene gl-ucoside from Portulaca oleracea. Phytochemistry 1996; 42: 1625-1628.
21. Mizutani M, Hashidoko Y and Tahara S. Factors responsible for inhibiting the motility of zoo-spores of the phytopathogenic fungus Aph-anomyces cochlioides isolated from the non-host plant Portulaca oleracea. FEBS Lett 1998; 438: 236-240.
22. Feng PC. High concentration of (-)-noradrena-line in Portulaca oleracea L. Nature 1961; 191: 1108.
23. Chen CJ, Wang WY, Wang XL, Dong LW, Yue YT, Xin HL, Ling CQ and Li M. Anti-hypoxic activity of the ethanol extract from Portulaca oleracea in mice. J Ethnopharmacol 2009; 124: 246-250.
24. Changquan L, Liwei D, Hailiang X, Min L, Wa-nyin W and Lin J. Ethanol extract of Portulaca oleracea L. protects against hypoxia-induced neuro damage through modulating endogenous erythropoietin expression. J Nutr Biochem 2014; 23: 385-391.
25. Llacuna L, Marí M, Lluis JM, García-Ruiz C, Fernández-Checa JC and Morales A. Reactive oxygen species mediate liver injury through pa-renchymal nuclear factor-κB inactivation in prolonged ischemia/reperfusion. Am J Pathol 2009; 174: 1776-1785.
26. Gunawan BK, Liu ZX, Han D, Hanawa N, Gaarde WA and Kaplowitz N. c-Jun N-terminal kinase plays a major role in murine acetaminophen hepatotoxicity. Gastroenterology 2006; 131: 165-178.
27. Henderson NC, Pollock KJ, Frew J, Mackinnon AC, Flavell RA, Davis RJ, Sethi T and Simpson KJ. Critical role of c-jun (NH2) terminal kinase in paracetamol-induced acute liver failure. Gut 2007; 56: 982-990.
28. Martin-Murphy BV, Kominsky DJ, Orlicky DJ, Donohue TM and Ju C. Increased susceptibility of natural killer T-cell-deficient mice to acet-aminophen-induced liver injury. Hepatology 2013; 57: 1575-1584.
29. Larson AM, Polson J, Fontana RJ, Davern TJ, Lalani E, Hynan LS, Reisch JS, Schiødt FV, Ostapowicz G and Shakil AO. Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study. Hepatology 2005; 42: 1364-1372.
30. Knight TR, Kurtz A, Bajt ML, Hinson JA and Jaeschke H. Vascular and hepatocellular per-oxynitrite formation during acetaminophen toxicity: role of mitochondrial oxidant stress. Toxicol Sci 2001; 62: 212-220.
31. Tirmenstein MA and Nelson SD. Acetamino-phen-induced oxidation of protein thiols. Co-ntribution of impaired thiol-metabolizing en-zymes and the breakdown of adenine nucleo-tides. J Bio Chem 1990; 265: 3059-3065.
32. Hanawa N, Shinohara M, Saberi B, Gaarde WA, Han D and Kaplowitz N. Role of JNK transloca-tion to mitochondria leading to inhibition of mitochondria bioenergetics in acetaminophen-induced liver injury. J Bio Chem 2008; 283: 13565-13577.
33. Rogina B and Helfand SL. Cu, Zn superoxide dismutase deficiencyaccelerates the time co-urse of an age-related markerin Drosophila melanogaster. Biogerontology 2000; 1: 163-169.
34. Yu Y, Li J, Wan Y, Lu J, Gao J and Huang C. GAD-D45α Induction by Nickel Negatively Regulates JNKs/p38 Activation via Promoting PP2Cα Expression. PLoS One 2013; 8: e57185.
35. Han D, Ybanez MD, Ahmadi S, Yeh K and Kaplowitz N. Redox regulation of tumor necrosis factor signaling. Antioxid Redox Signal 2009; 11: 2245-2263.